Leonard Vernon
Career history of Leonard Vernon
Former positions of Leonard Vernon
| Companies | Position | Start | End |
|---|---|---|---|
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Chief Administrative Officer | 2011-01-16 | - |
| Director of Finance/CFO | 2011-01-16 | - | |
MTS Allstream, Inc.
 MTS Allstream, Inc. Specialty TelecommunicationsCommunications MTS Allstream, Inc. provides communication and information technology solutions. It provides wire-line voice, high-speed Internet and data, wireless, directory, digital television, security, and alarm monitoring services. The company serves residential and business customers in Manitoba. MTS Allstream was founded in 1983 and is headquartered in Winnipeg, Canada | Chief Administrative Officer | - | - |
| Director of Finance/CFO | - | - |
Statistics
International
| Canada | 2 |
| United Kingdom | 2 |
Operational
| Chief Administrative Officer | 2 |
| Director of Finance/CFO | 2 |
Sectoral
| Communications | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
MTS Allstream, Inc.
MTS Allstream, Inc. Specialty TelecommunicationsCommunications MTS Allstream, Inc. provides communication and information technology solutions. It provides wire-line voice, high-speed Internet and data, wireless, directory, digital television, security, and alarm monitoring services. The company serves residential and business customers in Manitoba. MTS Allstream was founded in 1983 and is headquartered in Winnipeg, Canada | Communications |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Leonard Vernon
- Experience
